Anne-Laure Joly

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: CLINICAL IMMUNOLOGY. 2022;237:108957
The FOXP3 full-length isoform controls the lineage-stability of CD4⁺FOXP3⁺ regulatory T cells
Seitz C; Joly A-L; Fang F; Frith K; Gray P; Andersson J
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(44):27556-27565
MNK2 governs the macrophage antiinflammatory phenotype
Bartish M; Tong D; Pan Y; Wallerius M; Liu H; Ristau J; Ferreira SDS; Wallmann T; van Hoef V; Masvidal L; Kerzel T; Joly A-L; Goncalves C; Preston SEJ; Ebrahimian T; Seitz C; Bergh J; Pietras K; Lehoux S; Naldini L; Andersson J; Squadrito ML; del RSV; Larsson O; Rolny C
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2019;144(1):317-320.e8
The FOXP3Δ2 isoform supports Treg cell development and protects against severe IPEX syndrome
Frith K; Joly A-L; Ma CS; Tangye SG; Lohse Z; Seitz C; Verge CF; Andersson J; Gray P
Article: JOURNAL OF AUTOIMMUNITY. 2019;98:86-94
Multi-faceted inhibition of dendritic cell function by CD4⁺ Foxp3⁺ regulatory T cells
Seitz C; Liu S; Klocke K; Joly A-L; Czarnewski PV; Tibbitt CA; Parigi SM; Westerberg LS; Coquet JM; Villablanca EJ; Wing K; Andersson J
Article: ISCIENCE. 2018;9:71-83
Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity
Wallmann T; Zhang X-M; Wallerius M; Bolin S; Joly A-L; Sobocki C; Leiss L; Jiang Y; Bergh J; Holland EC; Enger PO; Andersson J; Swartling FJ; Miletic H; Uhrbom L; Harris RA; Rolny C
Article: CIRCULATION RESEARCH. 2018;122(10):1385-1394
Alternative Splicing of FOXP3 Controls Regulatory T Cell Effector Functions and Is Associated With Human Atherosclerotic Plaque Stability
Joly A-L; Seitz C; Liu S; Kuznetsov NV; Gertow K; Westerberg LS; Paulsson-Berne G; Hansson GK; Andersson J
Article: JCI INSIGHT. 2017;2(6):e90531
Serum Gp96 is a chaperone of complement-C3 during graft-versus-host disease.
Seignez A; Joly A-L; Chaumonnot K; Hazoumé A; Sanka M; Marcion G; Boudesco C; Hammann A; Seigneuric R; Jégo G; Ducoroy P; Delarue P; Senet P; Castilla-Llorente C; Solary E; Durey M-A; Rubio M-T; Hermine O; Kohli E; Garrido C
Article: ONCOGENE. 2016;35(22):2842-2851
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.
Joly A-L; Deepti A; Seignez A; Goloudina A; Hebrard S; Schmitt E; Richaud S; Fourmaux E; Hammann A; Collura A; Svrcek M; Jego G; Robinet E; Solary E; Demidov O; Kohli E; Garrido C
Article: SCIENTIFIC REPORTS. 2015;5:14674
IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3
Mailer RKW; Joly A-L; Liu S; Elias S; Tegner J; Andersson J
Article: JOURNAL OF AUTOIMMUNITY. 2015;63:23-30
Foxp3 lacking exons 2 and 7 is unable to confer suppressive ability to regulatory T cells in vivo
Joly A-L; Liu S; Dahlberg CIM; Mailer RKW; Westerberg LS; Andersson J
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2015;81(5):318-324
Immunological Profiling of Haemodialysis Patients and Young Healthy Individuals with Implications for Clinical Regulatory T Cell Sorting
Bergstrom M; Joly A-L; Seiron P; Isringhausen S; Modig E; Fellstrom B; Andersson J; Berglund D
Article: FASEB JOURNAL. 2013;27(10):4169-4183
Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3.
Thuringer D; Jego G; Wettstein G; Terrier O; Cronier L; Yousfi N; Hébrard S; Bouchot A; Hazoumé A; Joly A-L; Gleave M; Rosa-Calatrava M; Solary E; Garrido C
Article: NATURE MEDICINE. 2011;17(10):1283-1289
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.
Dorard C; de Thonel A; Collura A; Marisa L; Svrcek M; Lagrange A; Jego G; Wanherdrick K; Joly AL; Buhard O; Gobbo J; Penard-Lacronique V; Zouali H; Tubacher E; Kirzin S; Selves J; Milano G; Etienne-Grimaldi M-C; Bengrine-Lefèvre L; Louvet C; Tournigand C; Lefèvre JH; Parc Y; Tiret E; Fléjou J-F; Gaub M-P; Garrido C; Duval A
Article: FRONTIERS IN ONCOLOGY. 2011;1:37
Heat shock proteins as danger signals for cancer detection.
Seigneuric R; Mjahed H; Gobbo J; Joly A-L; Berthenet K; Shirley S; Garrido C
Article: ONCOGENE. 2009;28(37):3332-3344
Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity.
Brunet Simioni M; De Thonel A; Hammann A; Joly AL; Bossis G; Fourmaux E; Bouchot A; Landry J; Piechaczyk M; Garrido C

Alla övriga publikationer

Editorial comment: AGING-US. 2019;11(7):1905-1906
Alternative splicing, FOXP3 and cardiovascular disease
Joly A-L; Andersson J
Corrigendum: ONCOGENE. 2016;35(22):2948
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development.
Joly A-L; Deepti A; Seignez A; Goloudina A; Hebrard S; Schmitt E; Richaud S; Fourmaux E; Hammann A; Collura A; Svrcek M; Jego G; Robinet E; Solary E; Demidov O; Kohli E; Garrido C
Corrigendum: ONCOGENE. 2016;35(22)
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development (vol 35, pg 2842, 2016)
Joly A-L; Deepti A; Seignez A; Goloudina A; Hebrard S; Schmitt E; Richaud S; Fourmaux E; Hammann A; Collura A; Svrcek M; Jego G; Robinet E; Solary E; Demidov O; Kohli E; Garrido C
Review: JOURNAL OF INNATE IMMUNITY. 2010;2(3):238-247
Dual role of heat shock proteins as regulators of apoptosis and innate immunity.
Joly A-L; Wettstein G; Mignot G; Ghiringhelli F; Garrido C
Review: CURRENT MEDICINAL CHEMISTRY. 2007;14(27):2839-2847
Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins.
Didelot C; Lanneau D; Brunet M; Joly A-L; De Thonel A; Chiosis G; Garrido C

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI